Active Biotech AB Cash Flow Reinvestment Rate
Latest as of June 2019:
0.00x
Active Biotech AB cash flow reinvestment rate. Active Biotech AB (ACTI) has a Cash Flow Reinvestment Rate of 0.00x as of June 2019, reinvesting Skr0.00 (capex Skr0.00 ) from operating cash flow of Skr262.60 Million. Explore ACTI debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
Skr0.00
Capex + Investments
Operating Cash Flow
Skr262.60 Million
SEK
Capital Expenditures
Skr0.00
SEK
Active Biotech AB Cash Flow Reinvestment Rate by Year (None–None)
Active Biotech AB cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Active Biotech AB. For the full cash flow conversion analysis, see cash flow conversion of Active Biotech AB.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow